CONTACT

Do you have patients with invasive pulmonary aspergillosis?

They may be suitable to participate in a phase 3 study evaluating the safety and efficacy of an investigational inhaled antifungal medication.

Pulmocide is conducting a phase 3 clinical research study in invasive pulmonary aspergillosis. If you have patients with this condition, please consider them for this pivotal trial.

For more information on this clinical trial, visit ClinicalTrials.gov.

Want to learn more?

Please fill out the form below, and a clinical research representative will contact you to provide information regarding potential options for participation in this study.

*Required field

By clicking submit, you agree to provide the information above to Pulmocide and agents acting on behalf of Pulmocide to contact you regarding information related to this investigational study only and have read our Privacy Notice and Cookie Policy.

For more information, visit Pulmocide.com or email us here.

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Youtube
Consent to display content from - Youtube
Vimeo
Consent to display content from - Vimeo
Google Maps
Consent to display content from - Google
Spotify
Consent to display content from - Spotify
Sound Cloud
Consent to display content from - Sound
Save